Financials
- Market Capitalization 13.36 M
- Employee 24
- Founded 2003
- CEO Philip A. Serlin
- Website www.biolinerx.com
- Headquarter Israel
- FIGI BBG001Y26LK0
- Industry Biyoteknoloji
Toplam gelir
Net kar
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 4729 | GTBP GT Biopharma, Inc. - Common Stock | 0.36 USD | -7.69% | -21.74% | -25.00% | -83.18% | 12.98 M USD | ||
| 4730 | QNCX Quince Therapeutics, Inc. - Common Stock | 17.61 USD | +2.09% | +7.44% | +1793.55% | +872.93% | 14.35 M USD | ||
| 4744 | INTS Intensity Therapeutics, Inc. - Common Stock | 4.90 USD | -0.41% | -1.01% | +33.88% | +1384.85% | 13.24 M USD | ||
| 4748 | COCP Cocrystal Pharma, Inc. - Common Stock | 0.96 USD | 0.00% | -5.88% | -3.03% | -44.19% | 13.24 M USD |